MedTech Startup Focused on Home Monitoring for Patients with Congestive Heart Failure and Other Chronic Diseases Wins the 2021 ICI Pitch Competition and $200,000 Award TEL AVIV, Israel
/PRNewswire/ E&T Magazine, the official publication of the Institution of Engineering and Technology (IET), presented its "Future Unicorn" award to Donisi.
MedTech Startup Focused on Home Monitoring for Patients with Congestive Heart Failure and Other Chronic Diseases Receives the "Future Unicorn" Innovation Award from E&T TEL AVIV, Israel
Share this article
Share this article
TEL AVIV, Israel, May 5, 2021 /PRNewswire/ The U.S. Food and Drug Administration (FDA) has granted Donisi s revolutionary contact-free multiparameter measurement system de novo clearance, making Donisi the first to bring this innovative technology to the medical market.
In addition to the de novo clearance, the ingenuity of Donisi s groundbreaking system was recently recognized via the publication of their clinical validation study in the Journal of Medical Engineering & Technology and winning first place in the MEDinISRAEL OpenMED Innovation Competition.
Contact-Free Health Measurement and Decision Support. Donisi: Changing Lives Without Changing Lifestyles I m really proud of our team; we developed a medical device that can change the lives of millions of people. Our novel technology is now recognized and cleared by FDA which is a great accomplishment, said Donisi CEO, Yair Brosh.